Pharmaceutical policy in countries with developing healthcare systems: Synthesis of country case studies

Warren Kaplan; Nikolina Boskovic; Daniel Flanagan; Serafina Lalany; Chia Ying Lin; Zaheer Ud Din Babar

doi:10.1007/978-3-319-51673-8_20

Pharmaceutical policy in countries with developing healthcare systems: Synthesis of country case studies

Warren Kaplan, Nikolina Boskovic, Daniel Flanagan, Serafina Lalany, Chia Ying Lin, Zaheer Ud Din Babar

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

3 Citations (Scopus)

Abstract

This chapter attempts to synthesize information taken from the various country chapters in this volume. To do this, we created a template (see Appendix 20.1) from which information is extracted from the various country profiles. Each of the country profiles generally followed a preset format, and the template was designed to mimic this by having various “domains” (see below). We searched the documents for key terms to aid in filling out the template. Data used to generate the figures in this chapter were compiled from both the completed templates and from data generated by the World Health Organization (http://www.who.int/healthinfo/statistics/en/) and the World Bank (http://data.worldbank.org/indicator).

Original language	English
Title of host publication	Pharmaceutical Policy in Countries with Developing Healthcare Systems
Publisher	Springer International Publishing AG
Pages	405-430
Number of pages	26
ISBN (Electronic)	9783319516738
ISBN (Print)	9783319516721
DOIs	https://doi.org/10.1007/978-3-319-51673-8_20
Publication status	Published - 1 Jan 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-319-51673-8_20

Cite this

@inbook{8ac8f922b183414c884c52014c473f84,

title = "Pharmaceutical policy in countries with developing healthcare systems: Synthesis of country case studies",

abstract = "This chapter attempts to synthesize information taken from the various country chapters in this volume. To do this, we created a template (see Appendix 20.1) from which information is extracted from the various country profiles. Each of the country profiles generally followed a preset format, and the template was designed to mimic this by having various “domains” (see below). We searched the documents for key terms to aid in filling out the template. Data used to generate the figures in this chapter were compiled from both the completed templates and from data generated by the World Health Organization (http://www.who.int/healthinfo/statistics/en/) and the World Bank (http://data.worldbank.org/indicator).",

author = "Warren Kaplan and Nikolina Boskovic and Daniel Flanagan and Serafina Lalany and Lin, {Chia Ying} and Babar, {Zaheer Ud Din}",

year = "2017",

month = jan,

day = "1",

doi = "10.1007/978-3-319-51673-8_20",

language = "English",

isbn = "9783319516721",

pages = "405--430",

booktitle = "Pharmaceutical Policy in Countries with Developing Healthcare Systems",

publisher = "Springer International Publishing AG",

address = "Switzerland",

}

Pharmaceutical policy in countries with developing healthcare systems : Synthesis of country case studies. / Kaplan, Warren; Boskovic, Nikolina; Flanagan, Daniel et al.

Pharmaceutical Policy in Countries with Developing Healthcare Systems. Springer International Publishing AG, 2017. p. 405-430.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

TY - CHAP

T1 - Pharmaceutical policy in countries with developing healthcare systems

T2 - Synthesis of country case studies

AU - Kaplan, Warren

AU - Boskovic, Nikolina

AU - Flanagan, Daniel

AU - Lalany, Serafina

AU - Lin, Chia Ying

AU - Babar, Zaheer Ud Din

PY - 2017/1/1

Y1 - 2017/1/1

N2 - This chapter attempts to synthesize information taken from the various country chapters in this volume. To do this, we created a template (see Appendix 20.1) from which information is extracted from the various country profiles. Each of the country profiles generally followed a preset format, and the template was designed to mimic this by having various “domains” (see below). We searched the documents for key terms to aid in filling out the template. Data used to generate the figures in this chapter were compiled from both the completed templates and from data generated by the World Health Organization (http://www.who.int/healthinfo/statistics/en/) and the World Bank (http://data.worldbank.org/indicator).

AB - This chapter attempts to synthesize information taken from the various country chapters in this volume. To do this, we created a template (see Appendix 20.1) from which information is extracted from the various country profiles. Each of the country profiles generally followed a preset format, and the template was designed to mimic this by having various “domains” (see below). We searched the documents for key terms to aid in filling out the template. Data used to generate the figures in this chapter were compiled from both the completed templates and from data generated by the World Health Organization (http://www.who.int/healthinfo/statistics/en/) and the World Bank (http://data.worldbank.org/indicator).

UR - http://www.scopus.com/inward/record.url?scp=85034407005&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-51673-8_20

DO - 10.1007/978-3-319-51673-8_20

M3 - Chapter

AN - SCOPUS:85034407005

SN - 9783319516721

SP - 405

EP - 430

BT - Pharmaceutical Policy in Countries with Developing Healthcare Systems

PB - Springer International Publishing AG

ER -

Pharmaceutical policy in countries with developing healthcare systems: Synthesis of country case studies

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this